Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Country / region: Finland Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20083
20094
20101
20121
20131
20144
20151
20162
20182
20201
20212
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14
Completed12
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Pfizer4
Biogen3
Eli Lilly and Company3
GlaxoSmithKline2
H. Lundbeck A/S2
TauRx Therapeutics Ltd2
Bristol-Myers Squibb1
Medivation, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease27
Dementia7
Neurodegenerative Diseases4
Brain Diseases3
Cognitive Dysfunction3
Mental Disorders2
Nervous System Diseases2
Central Nervous System Diseases1
Frontotemporal Dementia1
Lymphoma, Follicular1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.